Next Article in Journal
Synthesis of a Building Block for Oligopeptide-Oligonucleotide Conjugates
Previous Article in Journal
Antispasmodic Activity of Semi-Synthetic Secoisopimarane Derivatives
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 7
10.3797/scipharm.oephg.21.PO-17
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine

by
P. OLEJNÍKOVÁ
1,
L. BIROŠOVÁ
1,* and
L. ŠVORC
2
1
Institute of Biochemistry, Nutrition and Health Protection, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 812 37 Bratislava, Slovakia
2
Institute of Analytical Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 812 37 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 216; https://doi.org/10.3797/scipharm.oephg.21.PO-17
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Abstract

Microbial diseases still pose a threat for the population as a consequence of increasing number of microbial strains resistant to antibiotics and chemo-therapeutics of common use. Their treatment remains an important and challenging worldwide problem. There is real perceived need for the discovery of new compounds endowed with antimicrobial activity, possibly acting though mechanisms of action, which are distinct from those of well-known classes of antibacterial agents to which many clinically relevant pathogens are now resistant. Indolizines, the nitrogen containing heterocyclic systems, have been widely distributed in nature.[....]

Share and Cite

MDPI and ACS Style

OLEJNÍKOVÁ, P.; BIROŠOVÁ, L.; ŠVORC, L. Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine. Sci. Pharm. 2009, 77, 216. https://doi.org/10.3797/scipharm.oephg.21.PO-17

AMA Style

OLEJNÍKOVÁ P, BIROŠOVÁ L, ŠVORC L. Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine. Scientia Pharmaceutica. 2009; 77(Posters (PO)):216. https://doi.org/10.3797/scipharm.oephg.21.PO-17

Chicago/Turabian Style

OLEJNÍKOVÁ, P., L. BIROŠOVÁ, and L. ŠVORC. 2009. "Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine" Scientia Pharmaceutica 77, Posters (PO): 216. https://doi.org/10.3797/scipharm.oephg.21.PO-17

APA Style

OLEJNÍKOVÁ, P., BIROŠOVÁ, L., & ŠVORC, L. (2009). Antimicrobial and Antimutagenic Properties of Newly Synthesized Derivatives of Indolizine. Scientia Pharmaceutica, 77(Posters (PO)), 216. https://doi.org/10.3797/scipharm.oephg.21.PO-17

Article Metrics

Back to TopTop